Pharmaceuticals
Bangladesh exported US$238.5 million of medicines in FY2025-26; Brazil imported US$14.5 billion of pharmaceuticals in 2025. Access runs through ANVISA registration and a Brazilian registration holder.
Key figures
- Bangladesh's pharmaceutical exports in FY2025-26
- US$238.5 m
- Source: Export Promotion Bureau (EPB), Bangladesh · FY2025-26 (July 2025–June 2026); published Jul 2026
- Brazil's pharmaceutical imports (HS 30) in 2025
- US$14.5 bn
- Source: ComexStat, Brazil's official foreign-trade statistics (MDIC/Secex) — HS 30 · 2025 data; database updated 6 Oct 2026
- Brazil's import duty on medicines in retail packs (HS 3004), by product
- 0–12.6%
- Source: MDIC/Camex tariff file (TEC) and TIPI, Brazil · Tariff file dated 5 Oct 2026
The sector in detail
HS chapters
- 30
Brazil's NCM codes begin with these Harmonized System chapters. Confirm the full code of each product with a customs broker.
Bangladesh's pharmaceutical exports reached US$238.5 million in FY2025-26. Sales to Brazil are still very small — about US$0.3 million — while Brazil imported US$14.5 billion of pharmaceutical products in 2025.
Market access is regulatory. A medicine must be registered with ANVISA, Brazil's health regulator, and the foreign maker needs a local registration holder: its own unit or office in Brazil, or an authorised Brazilian distributor. Timelines vary case by case.
Brazil's import duty on medicines in retail packs ranges from 0% to 12.6% depending on the product, and many specific medicines are at 0% under Brazil's exception list. PIS/COFINS-Importação on pharmaceuticals uses special rates.
At the expo, medicines not registered with ANVISA may not enter Brazil for exhibition or demonstration. Exhibit with dossiers, certificates, product lists and plant videos instead of product samples.
Exhibited in 2025
Companies from this sector at the 2025 edition in São Paulo.
-
Biocell
-
Chemist
Take part in São Paulo
22–25 March 2027 · São Paulo, Brazil